Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule featuring a benzenesulfonamide core linked via an amino group to a pyrimidine ring substituted with a 5-chloro-benzodioxole moiety. It is classified as an experimental drug and has not been approved for any clinical use. The compound has been referenced in chemical and pharmacological databases but lacks published information on its mechanism of action or therapeutic indication. No clinical trials or regulatory approvals are reported for this molecule[4][7]. Its structure suggests it may have been investigated as a kinase inhibitor or molecular probe in research settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide.